JASPER THERAPEUTICS INC Share Price Today: Live Updates & Key Insights

JASPER THERAPEUTICS INC share price today is $1.2064, up 0.82%. The stock opened at $1.25 against the previous close of $1.22, with an intraday high of $1.265 and low of $1.215.

JASPER THERAPEUTICS INC Share Price Chart

JASPER THERAPEUTICS INC

us-stock
To Invest in {{usstockname}}
us-stock

JASPER THERAPEUTICS INC Share Price Performance

$1.2064 0.0082(0.82%) JSPR at 23 Mar 2026 01:50 PM Biotechnology
Lowest Today 1.215
Highest Today 1.265
Today’s Open 1.25
Prev. Close 1.22
52 Week High 7.19
52 Week Low 1.11
Day’s Range: Low 1.215 High 1.265
52-Week Range: Low 1.11 High 7.19
1 day return -
1 Week return -0.8
1 month return -10.86
3 month return -34.57
6 month return -51.57
1 year return -76.52
3 year return -93.61
5 year return -98.75
10 year return -

JASPER THERAPEUTICS INC Institutional Holdings

Velan Capital Investment Management LP 9.54

Soleus Capital Management, L.P. 5.34

Vanguard Group Inc 4.74

Rock Springs Capital Management LP 3.93

Millennium Management LLC 3.84

The Carlyle Group Inc 3.81

Woodline Partners LP 3.72

T. Rowe Price Investment Management,Inc. 3.68

Qiming U.S. Ventures Management, LLC 3.32

Vanguard Total Stock Mkt Idx Inv 2.98

BOOTHBAY FUND MANAGEMENT, LLC 2.84

Morgan Stanley - Brokerage Accounts 2.82

Sphera Funds Management Ltd. 1.73

Lion Point Capital, LP 1.42

T. Rowe Price Small-Cap Value 1.41

T. Rowe Price U.S. SC Value Eq Tr-D 1.38

Vanguard Institutional Extnd Mkt Idx Tr 1.12

Bank of America Corp 1.05

Squarepoint Ops LLC 1.01

Renaissance Technologies Corp 0.81

Geode Capital Management, LLC 0.76

BlackRock Inc 0.73

Knott David M Jr 0.65

Deutsche Bank AG 0.57

Fidelity Extended Market Index 0.46

iShares Micro-Cap ETF 0.25

Fidelity Total Market Index 0.18

Blackrock Extended Mkt Fund CF 0.11

Vanguard Balanced Index Inv 0.10

Extended Equity Market Fund K 0.09

T. Rowe Price U.S. Equities Tr 0.09

Fidelity Series Total Market Index 0.09

Deka-ESG Gesundheit CF 0.09

Vanguard Instl Ttl Stck Mkt Idx Tr 0.08

Telescope Biotech Fund A FIL 0.08

Spartan Total Market Index Pool G 0.06

Spartan Extended Market Index Pool F 0.06

Northern Trust Extended Eq Market Idx 0.05

NT Ext Equity Mkt Idx Fd - L 0.05

Fidelity VIP Disciplined Small Cap Init 0.04

JASPER THERAPEUTICS INC Market Status

Strong Buy: 7

Buy: 4

Hold: 0

Sell: 0

Strong Sell: 0

JASPER THERAPEUTICS INC Fundamentals

Market Cap 34.42 M

PB Ratio 2.9626

PE Ratio 0.0

Enterprise Value -14.92 M

Total Assets 79.90 M

Volume 216337

JASPER THERAPEUTICS INC Company Financials

Annual Revenue FY23:0 0.0M, FY22:13511000 13.5M, FY21:6196000 6.2M, FY20:0 0.0M, FY19:null 0.0M

Annual Profit FY23:null 0.0M, FY22:13511000 13.5M, FY21:6196000 6.2M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-61095000 -61.1M, FY22:-24174000 -24.2M, FY21:-23984000 -24.0M, FY20:-31669000 -31.7M, FY19:null 0.0M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-258000 -0.3M, Q1/2025:-279000 -0.3M, Q3/2024:null 0.0M, Q2/2024:-299000 -0.3M

Quarterly Net worth Q3/2025:-18736000 -18.7M, Q2/2025:-26723000 -26.7M, Q1/2025:-21241000 -21.2M, Q3/2024:-18637000 -18.6M, Q2/2024:-14583000 -14.6M

About JASPER THERAPEUTICS INC & investment objective

Company Information Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma, as well as conditioning agents for stem cell transplant in patients with sickle cell disease, Fanconi anemia, and severe combined immunodeficiency. Jasper Therapeutics, Inc. was founded in 2018 and is based in Redwood City, California.

Organisation Biotechnology

Employees 27

Industry Biotechnology

CEO Mr. Jeetinder Singh Mahal M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

JASPER THERAPEUTICS INC FAQs

What is the share price of JASPER THERAPEUTICS INC today?

The current share price of JASPER THERAPEUTICS INC is $1.2064.

Can I buy JASPER THERAPEUTICS INC shares in India?

Yes, Indian investors can buy JASPER THERAPEUTICS INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy JASPER THERAPEUTICS INC shares in India?

You can easily invest in JASPER THERAPEUTICS INC shares from India by:

Can I buy fractional shares of JASPER THERAPEUTICS INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of JASPER THERAPEUTICS INC?

JASPER THERAPEUTICS INC has a market cap of $34.42 M.

In which sector does JASPER THERAPEUTICS INC belong?

JASPER THERAPEUTICS INC operates in the Biotechnology sector.

What documents are required to invest in JASPER THERAPEUTICS INC stocks?

To invest, you typically need:

What is the PE and PB ratio of JASPER THERAPEUTICS INC?

The PE ratio of JASPER THERAPEUTICS INC is N/A and the PB ratio is 2.96.